Q² Solutions
2.6 out of 5 stars.
Write a review

About Q² Solutions

More About Us

Find your career at a global company where development is always encouraged and facilitated. Here you can learn from and be mentored by friendly, supportive and smart people, while doing work that matters: Turning Hope into Help. Discover more about Q² Solutions and how we're turning hope into help.  As a global clinical trial laboratory services organization, we deliver end-to-end lab services across the clinical trial continuum and the world from central laboratory services, including our global logistics capabilities, kit manufacturing, project management, and specimen management to our comprehensive test menu, including  flow cytometry, genomics, immunoassay, anatomic pathology, bioanalytical, etc. , and across a wide array of therapy areas, including oncology, infectious diseases, neurology, endocrinology, and many more.  As the clinical trial landscape evolves, we pride ourselves on being able to manage trials with increasing complexity, including studies with new and unique biomarkers, companion diagnostics (CDx), adaptive designs, and virtual trials. We provide scientific consultation on biomarker assay development across the breadth of development needs. We’ve managed 100 CDx engagements throughout the world and perform the role of the investigator when needed.  We continuously evaluate new laboratory technology, like next generation flow cytometry, next generation sequencing, translational bioinformatics, and digital pathology, as well as data and process related technology like our Laboratory Trial Management System (LTMS). We partner with our customers to centralize and control sample and testing information today and in the future. Today, we use real-time track and trace technology for improved specimen management and deploy innovative solutions. Our technology investments are modular and flexible, and we are piloting emerging technologies, like blockchain and artificial intelligence, so that in the future, as the clinical trial environment evolves, we will continue to be able to centralize and control sample and testing information on behalf of our customers, investigators, and patients. Whatever we do, we never forget who we’re doing it for.

Careers

Together, we can turn hope into help Our employees use their ability to be innovative, brave, and dedicated creating better healthcare to help our customers deliver solutions faster and more efficiently than ever before. Join our team and surround yourself with some of the world’s brightest scientists, therapeutic experts, thought leaders and seasoned professionals in the industry. You will be member of a valued and trusted company where you will have the chance to develop your skills and abilities while improving healthcare for future generations.

Our Vision

We are transforming into a next generation laboratory through: End-to-end lab service solutions – We deliver end-to-end lab services across the clinical trial continuum and the world from central laboratory services, including our global logistics capabilities, kit manufacturing, project management, and specimen management to our comprehensive test menu, including  flow cytometry, genomics, immunoassay, anatomic pathology, bioanalytical, etc. , and across a wide array of therapy areas, including oncology, infectious diseases, neurology, endocrinology, and many more.  To support customer needs and increasing demand, we continually invest in our global footprint, especially in China, our quality management system, and our global capacity. Complex trial execution – As the clinical trial landscape evolves, we pride ourselves on being able to manage trials with increasing complexity, including studies with new and unique biomarkers, companion diagnostics (CDx), adaptive designs, and virtual trials. We provide scientific consultation on biomarker assay development across the breadth of development needs. We’ve managed 100 CDx engagements throughout the world and perform the role of the investigator when needed.  We’ve designed kits and databases to support adaptive designs like umbrella, platform, and basket approaches, where allowable drug combinations and or treatment arms may change rapidly throughout the life of the study, or when multiple studies use the same screening requirements and or placebo control groups. And we’ve supported virtual studies, studies in which visits to an investigator site are eliminated or reduced, by enabling near patient collection, or the collection of specimens via nurses and phlebotomists at a patient’s home or at a storefront location. New technology and data assets – We continuously evaluate new laboratory technology, like next generation flow cytometry, next generation sequencing, translational bioinformatics, and digital pathology, as well as data and process related technology like our Laboratory Trial Management System (LTMS™). LTMS manages testing requirements, kit configuration, alerts, kit ordering, queries, lab reports, data transfers, sample tracking, and metrics generation. Investments in laboratory technology and LTMS also helps us to unlock the value of our data assets for our customers by providing better insights to drive continuous improvement and future offerings. Serving as a collaborative hub-and-spoke model to the industry – We partner with our customers to centralize and control sample and testing information today and in the future. Today, we use real-time track and trace technology for improved specimen management and deploy innovative solutions, like LTMS and Labmatrix®, from BioFortis, a Q2 Solutions company, to enable industry leading sample and consent tracking. LTMS, Labmatrix®, our CRO partnership model,  our third-party lab management offering, and our experience supporting trials with point-of-care devices ,help to streamline specimen management and tracking  and realize cost savings, faster contracting and improved study data for customers. Our technology investments are modular and flexible, and we are piloting emerging technologies, like blockchain and artificial intelligence, so that in the future, as the clinical trial environment evolves, we will continue to be able to centralize and control sample and testing information on behalf of our customers, investigators, and patients.

Giving Back

The key to Q2 Solutions’ sustainable success as a clinical trial laboratory services organization is that we care about the things that matter most: the safety and well-being of our teammates and customers the health and protection of our environment the relationships we establish in the communities where they live, work and serve Q2 Solutions supports several charitable organizations worldwide.  See more here: https://www.q2labsolutions.com/charitable-donations

Innovation

Clinical development study teams must contend with many challenges and complexities in developing and executing clinical trials. We have deployed innovative solutions, and are developing various initiatives, to support our customers and their study teams. These initiatives are categorized as: Digital Innovation At Q² Solutions, we have a dedicated Digital Innovation department focused on driving operational improvements and quality of our services. Using the Labmatrix® platform, a BioFortis (a Q² Solutions Company) technology, we’ve helped create agile and impactful solutions across the organization with the underpinnings of traceability, productivity, quality, and efficiency. Innovation Laboratories In the summer of 2021, Q² Solutions opened a new state of the art, custom designed laboratory space, known as Q² Solutions Innovation Laboratories. Located on the new IQVIA Innovation Park Campus, in the heart of the dynamic Research Triangle Park in central North Carolina, this facility creates an innovative scientific community that includes multiple laboratory disciplines from service lines including Large Molecule Bioanalytical, Vaccines Center of Excellence, Genomics Center of Excellence and Translational Science and Innovation Laboratory (TSAIL).

Company Details

Headquarters

Morrisville

Employees

5,001 to 10,000

Industry

Pharmaceutical & Biotechnology